#TaibaRare #RareMetabolicDisease #PatientAwareness #LipodystrophyAwareness #RareDisease #MetabolicHealth #WorldLipodystrophyDay #RareDisorders #ChronicIllness To view or add a comment, sign in Ashley Shoemaker, MD, MSci, of Vanderbilt Health discusses the FDA approval of setmelanotide (Imcivree), the first targeted therapy for acquired hypothalamic obesity in patients 4+ years
In sum, she told us: Obesity is a chronic disease thats treatable at any age
Whole-slide digital images were acquired using a NanoZoomer S60 (Hamamatsu Photonics, Shizuoka, Japan)
In the present study, both the early and late dose-titration groups showed significant glycemic improvement, whereas only the early dose-titration group showed significant improvement in weight loss
Medical interventions, such as ovulation-inducing medications, may be necessary in some cases
With our prior authorization support, Pensacola locals encounter fewer barriers to achieving their health goals